Firm awarded for excellence and innovation in the life science legal space.
Kenneth Schuler, a member of Latham & Watkins’ Intellectual Property Practice, is a seasoned patent litigator, with a particular emphasis in pharmaceutical patent litigation involving claims arising under the Hatch-Waxman Act.
Mr. Schuler joined Latham in 1994 after serving as a judicial clerk to Judge James B. Loken, United States Court of Appeals for the Eighth Circuit. Since joining Latham, Mr. Schuler has acquired extensive litigation experience in federal and state courts, as well as in commercial arbitrations. He has extensive trial experience, having been admitted to the Trial Bar of the Northern District of Illinois in 2002.
Mr. Schuler has handled a significant number of pharmaceutical and life sciences patent-related cases for clients such as Mallinckrodt Pharmaceuticals, Cadence Pharmaceuticals, Eagle Pharmaceuticals, Endo Pharmaceuticals, Boehringer-Ingelheim GmbH, Par Pharmaceuticals, and Alvogen. He also has substantial experience litigating other intellectual property matters, including patent, trade secrets, and trade dress suits, representing Overhead Door, ADA Carbon Solutions, Neuromedical Systems, Inc., and Libbey Glass, Inc., with respect to myriad technologies, including activated carbon, manufacturing, barrier system operators, oxygen barrier plastic containers, ATM networks, mass spectrometers, and diagnostics. Intellectual Asset Management magazine named Mr. Schuler to the IAM Patent 1000 from 2014-2019.